6Chen HS, Wu TE, Jap TS,et al. Beneficial effects of insulin on glycemic control and beta - cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short - term intensive insulin therapy. Diabetes Care 2008;31(10) :1927 -32.
7Chan JC, Gagliardino JJ, Baik SH,et al. Multitaceted deter- minants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009;32(2) : 227 - 233.
8Chan JCN, et al. Diabetes Care 2009;32:227 -233.
9中华医学会糖尿病分会.中国2型糖尿病防治指南(2010年版).
10Jellinger PS, Davidson JA, Blonde L, et al. Road maps to a- chieve glycemic control in type 2 diabetes mellitus : ACE/AACE Dia- betes Road Map Task Force. Endocr Pract 2007 ; 13 ( 3 ) :260 - 268.
3Pan C, Yang W, Barona JP, et al. Comparison of vildagliptin and acarbose monotherapy in patients with type 2 diabetes-Z 24-week, doubleblind,randomized trial. Diabet Med 208 ;25 :435 -441.
4Namvaran F, Azarpira N, Rahimi-Moghaddam P, et al. Polymorphism of peroxisome proliferator-activated-yeceptor γ ( PPARγ) Prol2Ala in the Iranian population: relation with insulin resistance and response to theatment to with pioglitazone in type 2 diabetes. Eur J Pharmacol 2011 ;671 : 1- 6.
